(Adnkronos) - I nuovi orizzonti diagnostici e terapeutici relativi alla salute del cervello sono al centro del 54° Congresso della Società Italiana di Neurologia, in svolgimento a Roma fino al 12 novembre. Alessandro Padovani, presidente della Società scientifica, traccia un bilancio dell’edizione in corso.
Category
🗞
NewsTranscript
00:00The main themes that revolve around the health of the brain from diseases related to inflammation to stroke and the new diagnostic horizons offered by biomarkers that allow the early recognition of many diseases, especially those neurodegenerative, are at the center of the 54th Congress of the Italian Society of Neurology, taking place in Rome until November 12.
00:25The president of the scientific society tracks a balance of the 2024 edition of the Congress.
00:55The progress of genetic engineering is making a splash in the treatment of Parkinson's disease.
01:18There are therapies for Parkinson's disease.
01:23There are some forms of Parkinson's disease due to genetic diseases or genetic alterations.
01:39On this, even the Aguzzi relationship indicates that genetic engineering is making giant steps and we will probably have personalized therapies according to the genetic predisposition.
01:51For Alzheimer's disease there are drugs that control the symptoms, but further steps are necessary.
01:58We need drugs that can prevent the disease, slow down the disease and maybe stop the disease.
02:04I would say that here the light at the end of the tunnel is getting a little clearer.
02:08I am not one of those who believe that you have to go too fast.
02:12If EMA will try, this will dramatically change our system, but in addition to the drugs that are currently being discussed in EMA, there are many others in development.
02:22I believe that even for Alzheimer's disease, without running, the future of the next few years is certainly satisfactory.